Top

Published in:

01-11-2020 | Guillain-Barré Syndrome | COVID-19

COVID-19 and its impact on neurological manifestations and mental health: the present scenario

Authors: Shehnaz Sultana, Venkateshwari Ananthapur

Published in: Neurological Sciences | Issue 11/2020

Abstract

Though the COVID-19 pandemic primarily affects pulmonary and cardiorenal functions, many healthcare and its allied groups reported neurological involvement of SARS-CoV-2 in combination with either pre-existing metabolic abnormalities, medical conditions, infections or even chronic to acute inflammatory episodes of the nervous system. The present review provides a fair outlook of the published literature and also the case reports with an emphasis on plausible mechanisms involved in neurological complications of the central and peripheral nervous systems. Awareness on the neuropsychiatric manifestations being discussed in this article should ideally help the medical community in early identification and effective management of potentially life-threatening neurological diseases.

Johns Hopkins University Coronavirus Resource Center: https://coronavirus.jhu.edu

Li Y, Wang M, Zhou Y, et al (2020) Acute cerebrovascular disease following COVID-19:A single center, retrospective, observational study, Lancet https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3550025/

Kanberg N, Ashton NJ, Andersson LM, Yilmaz A, Lindh M, Nilsson S, Price RW, Blennow K, Zetterberg H, Gisslén M (2020) Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. https://doi.org/10.1212/WNL.0000000000010111

Coolen T et al (2020) Early postmortem brain MRI findings in COVID-19 non- survivors. Neurology. https://doi.org/10.1212/WNL.0000000000010116

Natoli S, Oliveira V, Calabresi P, Maia LF, Pisani A (2020) Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol 27:1764–1773. https://doi.org/10.1111/ene.14277CrossRefPubMed

Gowrisankar YV, Clark MA (2016) Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures. J Neurochem 138(1):74–85. https://doi.org/10.1111/jnc.13641CrossRefPubMed

Li N, Ma WT, Pang M, Fan QL, Hua JL (2019) The commensal microbiota and viral infection: a comprehensive review. Front Immunol 10:1–16. https://doi.org/10.3389/fimmu.2019.01551CrossRef

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77:683. https://doi.org/10.1001/jamaneurol.2020.1127CrossRefPubMed

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ et al (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 7(1):11PubMedPubMedCentral

10.

Xiang P, Xu XM, Gao LL, Wang HZ, Xiong HF, Li RH, et al (2020) First case of 2019 novel coronavirus disease with encephalitis. ChinaXiv T202003, 00015

11.

Tu H, Tu S, Gao S, Shao A, Sheng J (2020) Current epidemiological and clinical features of COVID-19; a global perspective from China. J Inf Secur 81:1–9. https://doi.org/10.1016/j.jinf.2020.04.011CrossRef

12.

Solomon IH, Normandin E, Bhattacharyya S, Mukerji SS, Keller K, Ali AS, Adams G, Hornick JL, Padera RF Jr, Sabeti P (2020) Neuropathological features of Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMc2019373

13.

Sasannejad C, Ely EW, Lahiri S (2019) Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit Care 23(1):352CrossRefPubMedPubMedCentral

14.

Koyama S, Ishii KJ, Coban C, Akira S (2008) Innate immune response to viral infection. Cytokine 43:336–341CrossRefPubMed

15.

Sankowski R, Mader S, Valdes-Ferrer SI (2015) Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Front Cell Neurosci 9:28CrossRefPubMedPubMedCentral

16.

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B (2020) COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 201187. https://doi.org/10.1148/radiol.2020201187

17.

Hirano T, Murakami M (2020) COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity 52:731–733. https://doi.org/10.1016/j.imunni.2020.04.003CrossRefPubMedPubMedCentral

18.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034. https://doi.org/10.1016/S0140-6736(20)30628-0CrossRefPubMedPubMedCentral

19.

Iwasaki A, Yang Y (2020) The potential danger of suboptimal antibody responses in COVID-19. Nat Rev Immunol 20:339–341CrossRefPubMedPubMedCentral

20.

Perrin P, Collongues N, Baloglu S et al (2020) Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Preprint June 2020. https://doi.org/10.20944/preprints202006.0103.v1

21.

Wang W, Tang J, Wei F (2020) Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol 92(4):441–447. https://doi.org/10.1002/jmv.25689CrossRefPubMedPubMedCentral

22.

Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 87:18–22. https://doi.org/10.1016/j.bbi.2020.03.031CrossRefPubMedPubMedCentral

23.

Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G (2020) COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev 53:66–70. https://doi.org/10.1016/j.cytogfr.2020.05.002CrossRefPubMedPubMedCentral

24.

Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, Humphries F, Jäger HR, Losseff NA, Perry RJ, Shah S, Simister RJ, Turner D, Chandratheva A, Werring DJ (2020) Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 0:1–3. https://doi.org/10.1136/jnnp-2020-323586CrossRef

25.

Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, Chen H, Wang D, Liu N, Liu D, Chen G, Zhang Y, Li D, Li J, Lian H, Niu S, Zhang L, Zhang J (2020) Characteristics of COVID-19 infection in Beijing. J Inf Secur 80:401–406. https://doi.org/10.1016/j.jinf.2020.02.018CrossRef

26.

Moriguchi T, Harii N, Goto J, Harada D et al (2020) A first case of meningitis/encephalitis associated with SARSCoronavirus-2. Int J Infect Dis. https://doi.org/10.1016/j.ijid.2020.03.062

27.

Duong L, Xu P, Lu A (2020) Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in downtown Los Angeles, Early Brain Behav Immun

28.

Ye M, Ren Y, Lv T (2020) Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun 88:945–946CrossRefPubMedPubMedCentral

29.

Pilotto A, Odolini S, Masciocchi S et al (2020) Steroid responsive encephalitis in Covid-19 disease. Ann Neurol. https://doi.org/10.1002/ana.25783

30.

Karimi N, Razavi AS, Rouhani N (2020) Frequent convulsive seizures in an adult patient with COVID-19: a case report. Iran Red Crescent Med J 22(3):e102828. https://doi.org/10.5812/ircmj.102828CrossRef

31.

Munz M, Wessendorf S, Koretsis G, Tewald F, Baegi R, Krämer S, Geissler M, Reinhard M (2020) Acute transverse myelitis after COVID-19 pneumonia. J Neurol 267:2196–2197. https://doi.org/10.1007/s00415-020-09934-wCrossRefPubMedPubMedCentral

32.

Sedaghat Z, Karimi N (2020) Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci 76:233–235CrossRefPubMedPubMedCentral

33.

Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, Guarrera GM, Giometto B (2020) Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci 41:1351–1354. https://doi.org/10.1007/s10072-020-04449-8CrossRefPubMedPubMedCentral

34.

Alberti P, Beretta S, Piatti M et al (2020) Guillain-Barre syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm 7:e741. https://doi.org/10.1212/NXI.0000000000000741CrossRefPubMedPubMedCentral

35.

Gutierrez-Ortiz C, Mendez A, Rodrigo-Rey S et al (2020) Miller fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. https://doi.org/10.1212/WNL.0000000000009619

36.

Guan W, Ni Z, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for Covid-19 (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. https://doi.org/10.1056/NEJMoa20020322020CrossRefPubMed

37.

Avula, et al. (2020) COVID-19 presenting as stroke. Brain Behav Immun

38.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J', Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513. https://doi.org/10.1016/S0140-6736(20)30211-7CrossRefPubMedPubMedCentral

39.

Mirzaee SMM, Goncalves FG, Mohammadifard M et al (2020) Focal cerebral arteriopathy in a COVID-19 paediatric patient. Radiology. https://doi.org/10.1148/radiol.2020202197

40.

Oxley T, Mocco J, Majidi S et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382(20):e60CrossRefPubMed

41.

Munir B, Rianawati SB, Kurniawan SN et al (2020) Neurological manifestation on hospitalized patient with probable COVID-19 in Saiful Anwar Hospital Indonesia (Serial Cases). Malang Neurol J 6: https://doi.org/10.21776/ub.mnj.2020.006.02.1

42.

Ashrafi F, Zali A, Ommi D, Salari M, Fatemi A, Arab-Ahmadi M, Behnam B, Azhideh A, Vahidi M, Yousefi-Asl M, Jalili khoshnood R, Advani S (2020) COVID-19-related strokes in adults below 55 years of age: a case series. Neurol Sci 41:1985–1989. https://doi.org/10.1007/s10072-020-04521-3CrossRefPubMedPubMedCentral

43.

Carvalho PM d M, Moreira MM, de Oliveira MNA, Landim JMM, Neto MLR (2020) The psychiatric impact of the novel coronavirus outbreak. Psychiatry Res 286:112902. https://doi.org/10.1016/j.psychres.2020.112902CrossRefPubMedPubMedCentral

44.

Pape K, Tamouza R, Leboyer M, Zipp F (2019) Immunoneuropsychiatry—novel perspectives on brain disorders. Nat Rev Neurol 15(6):317–328CrossRefPubMed

45.

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y et al (2020) Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 32161940. https://doi.org/10.1093/cid/ciaa248. In press

46.

Russell CD, Millar JE, Baillie JK (2020) Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395(10223):473–475CrossRefPubMedPubMedCentral

47.

Sato K, Mano T, Iwata A, Toda T (2020) Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database. Biosci Trends 14(2):139–143CrossRefPubMed

48.

Troyer EA, Kohn JN, Hong S (2020) Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun 32298803:34–39. https://doi.org/10.1016/j.bbi.2020.04.027CrossRef

49.

Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382:23–2270. https://doi.org/10.1056/NEJMc2008597CrossRef

50.

Yin R, Feng W, Wang T, Chen G, Wu T, Chen D et al (2020) Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019. J Med Virol. https://doi.org/10.1002/jmv.25888

51.

Hao F, Tan W, Jiang L, Zhang L, Zhao X, Zou Y, Hu Y, Luo X, Jiang X, McIntyre RS, Tran B, Sun J, Zhang Z, Ho R, Ho C, Tam W (2020) Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain Behav Immun 32353518:100–106. https://doi.org/10.1016/j.bbi.2020.04.069CrossRef

52.

Gonzalez-Sanguino C, Ausin B, Castellanos MA et al (2020) Mental health consequences during the initial stage of the 2020 coronavirus pandemic (COVID-19) in Spain. Brain Behav Immun 87:172–176CrossRefPubMedPubMedCentral

53.

Pappa S, Ntella V, Giannakas T, Giannakoulis VG, Papoutsi E, Katsaounou P (2020) Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis. Brain Behav Immun 88:901–907. https://doi.org/10.1016/j.bbi.2020.05.026CrossRefPubMedPubMedCentral

54.

Dosil-Santamaria M, Picaza-Gorrochategui M, Idoiaga-Mondragon N (2020) Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain. Cad Saúde Pública 36, e00054020

55.

Mowbray H (2020) In Beijing, coronavirus 2019-nCoV has created a siege mentality. Br Med J 368

56.

Bao Y, Sun Y, Meng S, Shi J, Lu L (2020) 2019-nCoV epidemic: address mental health care to empower society. Lancet 395:e37–e38. https://doi.org/10.1016/S0140-6736(20)30309-3CrossRefPubMedPubMedCentral

Title: COVID-19 and its impact on neurological manifestations and mental health: the present scenario
Authors: Shehnaz Sultana
Venkateshwari Ananthapur
Publication date: 01-11-2020
Publisher: Springer International Publishing
Keywords: Guillain-Barré Syndrome
Stroke
SARS-CoV-2
COVID-19
Cytokines
Published in: Neurological Sciences / Issue 11/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04695-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

COVID-19 and its impact on neurological manifestations and mental health: the present scenario

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2020

Clinical RoPE (cRoPE) score predicts patent foramen ovale detection among stroke patients: a multicenter observational study

Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review

“When should primary angiitis of the central nervous system (PACNS) be suspected?”: literature review and proposal of a preliminary screening algorithm

Italian validation of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ)

Features in essential tremor and the development of Parkinson’s disease vs. parkinsonism

The quality of measurement properties of neurocognitive assessment in brain tumor clinical trials over the last 30 years: a COSMIN checklist-based approach